Our findings study highlights the role of IRE1α downstream signaling in non-small cell lung cancer and opens a conceptual framework to determine how IRE1α endoribonuclease activity shapes the EMT program. This evidence concerns the gene ERN1 and non-small cell lung carcinoma.